New digital tool aims to boost fertility awareness in cancer patients

NCT ID NCT07642531

Not yet recruiting Knowledge-focused Sponsor: Biruni University Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study will develop and test a free, cloud-based platform to educate women aged 18-45 with early-stage gynecologic cancer about fertility preservation options. Researchers will compare awareness, knowledge, and attitudes between a group using the platform and a group receiving standard brochures. The goal is to see if the digital tool helps women make more informed decisions about their fertility.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: modular cloud-based educational platform
What this could lead to: If effective, this platform could become a free, scalable tool to help women with gynecologic cancer make informed decisions about fertility preservation.
What could go wrong: This is an early-stage trial testing awareness, not a treatment. The platform may not change actual behavior or outcomes, and results may not apply to other populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EARLY STAGE ENDOMETRIAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cervical carcinoma endometrial cancer fallopian tube cancer female reproductive organ cancer ovarian cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

FERTILITY PRESERVATION GYNECOLOGIC CANCERS

Contacts and locations

Locations

Biruni University

Istanbul, Zeytinburnu, 34020, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.